BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9893154)

  • 1. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences.
    Gold PW; Chrousos GP
    Proc Assoc Am Physicians; 1999; 111(1):22-34. PubMed ID: 9893154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The organization of the stress system and its dysregulation in depressive illness.
    Gold PW
    Mol Psychiatry; 2015 Feb; 20(1):32-47. PubMed ID: 25486982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
    Gold PW; Licinio J; Wong ML; Chrousos GP
    Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications.
    Gold PW; Gabry KE; Yasuda MR; Chrousos GP
    Endocrinol Metab Clin North Am; 2002 Mar; 31(1):37-62, vi. PubMed ID: 12055990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.
    Gold PW; Chrousos GP
    Mol Psychiatry; 2002; 7(3):254-75. PubMed ID: 11920153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.
    Tsigos C; Chrousos GP
    J Psychosom Res; 2002 Oct; 53(4):865-71. PubMed ID: 12377295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influences of chronic stress on central nervous systems].
    Asakura M; Nagashima H; Fujii S; Sasuga Y; Misonoh A; Hasegawa H; Osada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Aug; 20(3):97-105. PubMed ID: 11215156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Wong ML; Kling MA; Munson PJ; Listwak S; Licinio J; Prolo P; Karp B; McCutcheon IE; Geracioti TD; DeBellis MD; Rice KC; Goldstein DS; Veldhuis JD; Chrousos GP; Oldfield EH; McCann SM; Gold PW
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):325-30. PubMed ID: 10618417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress, norepinephrine and depression.
    Leonard BE
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S11-6. PubMed ID: 11590964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone in depression and post-traumatic stress disorder.
    Kasckow JW; Baker D; Geracioti TD
    Peptides; 2001 May; 22(5):845-51. PubMed ID: 11337099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-responsive neuromodulators.
    Gold PW
    Biol Psychiatry; 1988 Aug; 24(4):371-4. PubMed ID: 3044453
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor.
    Weiss JM; Stout JC; Aaron MF; Quan N; Owens MJ; Butler PD; Nemeroff CB
    Brain Res Bull; 1994; 35(5-6):561-72. PubMed ID: 7859114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes.
    Chrousos GP
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S50-5. PubMed ID: 10997609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro.
    Jedema HP; Grace AA
    J Neurosci; 2004 Oct; 24(43):9703-13. PubMed ID: 15509759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of corticotrophin releasing hormone 41 in depressive illness.
    Licinio J; Gold PW
    Baillieres Clin Endocrinol Metab; 1991 Mar; 5(1):51-8. PubMed ID: 2039428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PPARg System in Major Depression: Pathophysiologic and Therapeutic Implications.
    Gold PW
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings.
    Kling MA; Geracioti TD; Licinio J; Michelson D; Oldfield EH; Gold PW
    Psychopharmacol Bull; 1994; 30(3):489-94. PubMed ID: 7878187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses.
    Valentino RJ; Foote SL; Page ME
    Ann N Y Acad Sci; 1993 Oct; 697():173-88. PubMed ID: 7903030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats.
    Chen MF; Chiu TH; Lee EH
    Psychoneuroendocrinology; 1992; 17(2-3):113-24. PubMed ID: 1438640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.